HIV Glasgow 2016

aidsmap news from HIV Glasgow 2016

• Four days on, three days off HIV treatment controls viral load in French pilot study

  Treatment simplification strategies
  Keith Alcorn | 03 November 2016

  An experimental `four days on, three days off` antiretroviral regimen kept viral load fully suppressed in 96% of people for 48 weeks in a French study presented at the International Congress on ...

• Darunavir/ritonavir & lamivudine matches triple-drug therapy

  Treatment simplification strategies
  Keith Alcorn | 31 October 2016

  Simplifying antiretroviral therapy to a two-drug combination of lamivudine plus the protease inhibitor darunavir (Prezista) boosted by ritonavir is just as effective as a three-drug regimen in people with suppressed viral load, ...

• New long-acting fusion inhibitor albuvirtide plus boosted protease inibitor matches standard triple-drug therapy

  New and experimental HIV treatments
  Keith Alcorn | 28 October 2016

  A new fusion inhibitor, albuvirtide, under development in China, combined with a boosted protease inhibitor, proved just as effective as a triple regimen of lopinavir/ritonavir plus two nucleoside reverse transcriptase inhibitors (NRTIs) ...

• Generic hepatitis C drugs purchased online achieve high cure rates

  Hepatitis C treatment
  Keith Alcorn | 27 October 2016

  Use of generic versions of direct-acting antivirals resulted in very high cure rates for people who obtained the products through three buyers’ clubs, indicating that the generic products are effective, according to three ...

• Tests of online PrEP purchases by London clinic find no fakes, and adequate drug levels

  PrEP
  Gus Cairns | 26 October 2016

  A sexual health clinic in central London that offered to test drug levels in users of tenofovir/emtricitabine pre-exposure prophylaxis (PrEP) who had bought it online found adequate levels of both drugs in ...

• The benefit of treatment has outweighed the clinical impact of lipodystrophy, conference hears

  Lipodystrophy
  Gus Cairns | 26 October 2016

  The 2016 International Congress on Drug Therapy in HIV Infection (HIV Glasgow) heard today that over a 20-year period, people who suffered lipodystrophy (fat redistribution) and especially lipoatrophy (fat loss) when they ...

• French study reveals the growing complexity of medical needs as people with HIV age

  Ageing and HIV
  Keith Alcorn | 25 October 2016

  The complexity of the needs of people living with HIV will continue to increase as the population ages, and clinicians need to go beyond thinking about co-morbidities to consider multi-morbidities – clusters of ...

• Dolutegravir and central nervous system side-effects: abacavir, older age increase the risk

  Side-effects
  Keith Alcorn | 25 October 2016

  Insomnia, dizziness, headache and other central nervous system side-effects are occurring more frequently with everyday use of dolutegravir than clinical trials had suggested, and are most likely to occur in women, people over ...

• Two-drug HIV therapy just as effective as three-drug therapy

  Changing treatment
  Keith Alcorn | 25 October 2016

  Simplification of an antiretroviral treatment to a boosted protease inhibitor and the nucleoside analogue lamivudine (a dual regimen) is highly effective in people switching from a stable three-drug regimen, researchers reported on Monday ...

• New $90-$90-$90 target needed for global viral hepatitis, HIV and TB treatment

  Access to medicines and treatment
  Keith Alcorn | 24 October 2016

  The costs of making drugs to treat viral hepatitis, HIV and tuberculosis (TB) are now so low that each disease could be treated for less than $90, Dr Andrew Hill of St ...